COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Advances in Chemical Proteomics - 1st Edition - ISBN: 9780128214336

Advances in Chemical Proteomics

1st Edition

Editor: Xudong Yao
Paperback ISBN: 9780128214336
Imprint: Elsevier
Published Date: 1st April 2021
Page Count: 270
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Tool compounds for mass spectrometry-based chemical proteomics
2. Principles of proteomic reactions of covalent inhibitors
3. Reporter tags and chemistry for probe-reacted proteins
4. Chemical derivatization of peptides for quantitative proteomics
5. Database-searching strategies for probe-reacted proteins in a proteome
6. Solid-phase reagents for discovering inhibitors of kinases
7. Fragment screening for discovering covalent probes
8. Designer compounds for locational proteomics
9. Chemical proteomics for exploring protein lipidation Targeting Author: Edward Tate
10. Synthetic evolution of indocyanine green with the 2-nitroimidazole warhead for imaging of hypoxic tumor


Description

Advances in Chemical Proteomics provides essential concepts and recent applications on probes, tool compounds and concepts for chemical proteomics and then moves on to applications, including solid-phase reagents, fragment screening, designer compounds and protein lipidation. As the second volume in the Developments in Organic Chemistry series, each chapter is written by experts in the field. Users will find this to be a valuable reference for organic chemists and chemical biologists who are interested in developing tool compounds and reagents to measure and interrogate proteome, develop drug leads, and measure off-target effects and drug toxicity.

Analytical chemists who are interested in better understanding organic chemistry behind commonly used reagents for quantitative proteomics and tools compounds in the emerging field of chemical proteomics will also benefit from this comprehensive resource on the topics presented.

Key Features

  • Provides an ideal, introductory book to chemical proteomics for organic chemists, pharmaceutical chemists and chemical biologists
  • Includes advanced, recent applications and reviews in chemical proteomics
  • Presents valuable work by a global team of experts from the field of proteomics

Readership

Organic chemists and chemical biologists who are interested in developing tool compounds and reagents to measure the proteome, develop drug leads, measure drug toxicity. Pharmaceutical scientists


Details

No. of pages:
270
Language:
English
Copyright:
© Elsevier 2021
Published:
1st April 2021
Imprint:
Elsevier
Paperback ISBN:
9780128214336

Ratings and Reviews


About the Editor

Xudong Yao

Xudong Yao obtained his B.S. in synthetic polymer materials in July 1984 and M.S. in polymer chemistry in July 1987, both from Nanjing University in China. After working with the Department of Fiber Materials at China Textile University (now Donghua University) in Shanghai, he moved to the University of Maryland Baltimore County in the United States for doctoral studies in mechanistic enzymology with Prof. Ralph M. Pollack from August 1995 to October 1999. He then waded into the beginning streams of proteomics and did postdoctoral research in mass spectrometry and proteomics with Prof. Catherine Fenselau in the Department of Chemistry and Biochemistry at the University of Maryland until March 2002. During that time, he co-invented a highly cited quantitative proteomics technology of enzymatic 18O-labeling. Recruited by GeneProt, a Swiss company then in the spotlight, he flew to Geneva and made an ahead-of-its-time venture in the biggest gamble on proteomics industrialization. In October 2002, he joined Millennium Pharmaceuticals in Boston, continuing his industrial exploration in the uncharted land of the biosimilarity of protein drugs using mass spectrometry. He resumed his academic pursuit in August 2004, joining the Department of Chemistry at the University of Connecticut where he currently is an associate professor. His research activities are centered on the development and application of novel mass spectrometry and omics technologies.

Affiliations and Expertise

Associate Professor, Department of Chemistry and Institute for Systems Genomics, University of Connecticut, USA